Literature DB >> 10047645

Alternative approach to multivessel coronary disease with integrated coronary revascularization.

M Zenati1, H A Cohen, B P Griffith.   

Abstract

OBJECTIVE: Integrated coronary revascularization combines minimally invasive coronary artery bypass grafting (MICABG) with left internal thoracic artery-left anterior descending artery grafting and percutaneous coronary intervention. We hypothesized that integrated coronary revascularization could result in successful revascularization in suitable patients with multivessel coronary artery disease.
METHODS: Between September 1996 and January 1998, 31 consecutive patients underwent integrated coronary revascularization. Twenty-two were male; mean age was 69 years (46-86 years) and 42% were older than 75 years. Eight patients (26%) had a Parsonnet score greater than 20%. Left ventricular ejection fraction was 46.3% +/- 12%; 6 patients (19%) had a left ventricular ejection fraction less than 35%.
RESULTS: The anastomosis time for MICABG with the internal thoracic artery was 14.6 +/- 5.2 minutes and the operating time was 105 +/- 20 minutes; 28 patients (90%) were extubated in the operating room. The internal thoracic artery anastomosis was patent in all 31 patients (100%). Percutaneous coronary intervention was performed before MICABG in 2 patients (7%), on the same day of MICABG in 16 patients (52%), on postoperative day 1 in 3 patients (9%), and on postoperative days 2 to 4 in 10 patients (32%). Postprocedure length of stay in the hospital was 2.7 +/- 1.0 days and 13 patients (42%) were discharged home on postoperative day 1 or 2. Three patients (9.6%) required repeat target vessel revascularization in the distribution of the previous percutaneous coronary intervention. All patients are alive without angina at a follow-up of 10.8 +/- 3.8 months.
CONCLUSION: Our early results demonstrate that integrated coronary revascularization can be performed safely and effectively. Long-term results will be available from a prospective randomized trial now underway to compare integrated coronary revascularization with coronary artery bypass grafting for multivessel coronary artery disease.

Entities:  

Mesh:

Year:  1999        PMID: 10047645     DOI: 10.1016/s0022-5223(99)70322-3

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Current status of coronary artery bypass grafting.

Authors:  Junjiro Kobayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-06-18

Review 2.  Incomplete revascularization: what the surgeon needs to know.

Authors:  Dror B Leviner; Gianluca Torregrossa; John D Puskas
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 3.  Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.

Authors:  Ralf E Harskamp; Zhe Zheng; John H Alexander; Judson B Williams; Ying Xian; Michael E Halkos; J Matthew Brennan; Robbert J de Winter; Peter K Smith; Renato D Lopes
Journal:  Ann Thorac Surg       Date:  2013-12       Impact factor: 4.330

Review 4.  Combining PCI and CABG: the role of hybrid revascularization.

Authors:  Kelly D Green; Donald R Lynch; Tyffany P Chen; David Zhao
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

5.  Hybrid coronary revascularization as a safe, feasible, and viable alternative to conventional coronary artery bypass grafting: what is the current evidence?

Authors:  Arjan J F P Verhaegh; Ryan E Accord; Leen van Garsse; Jos G Maessen
Journal:  Minim Invasive Surg       Date:  2013-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.